Company Data

Puma Biotechnology Inc

Ticker
PBYI
Current Price
$2.86 -1.72%
Market Cap
$140.4M
Price Target
Refer to Report
Volume
201.6K
52wk Range
$2.225 - $7.73
Advanced Market Data

Overview

Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy